Share on StockTwits

JPMorgan Chase & Co. initiated coverage on shares of Aspen Aerogels (NASDAQ:ASPN) in a research note issued on Tuesday, TheFlyOnTheWall.com reports. The firm set an “overweight” rating and a $17.00 price target on the stock. JPMorgan Chase & Co.’s price objective would suggest a potential upside of 49.65% from the company’s current price.

The analysts wrote, “overweight”

Other equities research analysts have also recently issued reports about the stock. Analysts at Canaccord Genuity initiated coverage on shares of Aspen Aerogels in a research note on Tuesday. They set a “buy” rating and a $13.50 price target on the stock. Separately, analysts at Citigroup Inc. initiated coverage on shares of Aspen Aerogels in a research note on Tuesday. They set a “neutral” rating and a $12.00 price target on the stock. Finally, analysts at Robert W. Baird initiated coverage on shares of Aspen Aerogels in a research note on Tuesday. They set a “neutral” rating and a $11.00 price target on the stock. They noted that the move was a valuation call.

Aspen Aerogels (NASDAQ:ASPN) traded down 7.04% on Tuesday, hitting $10.56. The stock had a trading volume of 70,199 shares. Aspen Aerogels has a one year low of $10.25 and a one year high of $11.74. The stock’s 50-day moving average is $10. and its 200-day moving average is $10.. The company’s market cap is $217.3 million.

Aspen Aerogels, Inc is an energy technology company that designs, develops and manufactures aerogel insulation used primarily in large-scale energy infrastructure facilities.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.